• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated.

作者信息

Sears A V, Woolf R T, Gribaleva E, Abdelrahman W, Robbie S, Menon B, Kirkham B, Smith C H, Pink A E

机构信息

St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.

出版信息

Br J Dermatol. 2021 Apr;184(4):755-757. doi: 10.1111/bjd.19631. Epub 2021 Feb 28.

DOI:10.1111/bjd.19631
PMID:33107978
Abstract
摘要

相似文献

1
Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated.度普利尤单抗治疗成人特应性皮炎的真实世界有效性和耐受性：一项针对首批100例接受治疗患者的单中心、前瞻性1年观察性队列研究
Br J Dermatol. 2021 Apr;184(4):755-757. doi: 10.1111/bjd.19631. Epub 2021 Feb 28.
2
Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.真实世界中评估度普利尤单抗疗效和不良事件风险的证据：一项系统评价和荟萃分析。
J Am Acad Dermatol. 2021 Jan;84(1):139-147. doi: 10.1016/j.jaad.2020.08.051. Epub 2020 Aug 18.
3
Weight gain in patients with severe atopic dermatitis treated with dupilumab: a cohort study.使用度普利尤单抗治疗的重度特应性皮炎患者的体重增加：一项队列研究。
BMC Dermatol. 2020 Sep 22;20(1):8. doi: 10.1186/s12895-020-00103-0.
4
Real-world persistence with dupilumab among adults with atopic dermatitis.真实世界中成人特应性皮炎患者使用度普利尤单抗的持续性。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):40-45. doi: 10.1016/j.anai.2020.07.026. Epub 2020 Jul 31.
5
[Ocular symptoms associated with dupilumab in atopic dermatitis].[特应性皮炎中与度普利尤单抗相关的眼部症状]
Ned Tijdschr Geneeskd. 2019 Mar 21;163:D3227.
6
Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.特应性皮炎患者的度普利尤单抗相关性结膜炎。
Cornea. 2020 Jun;39(6):784-786. doi: 10.1097/ICO.0000000000002262.
7
Rosacea associated with dupilumab therapy.与度普利尤单抗治疗相关的酒渣鼻。
J Dermatolog Treat. 2021 Feb;32(1):114-116. doi: 10.1080/09546634.2019.1624683. Epub 2019 Jun 9.
8
Type 2 Inflammation: Atopic Dermatitis, Asthma, and Hypereosinophilia Successfully Treated With Dupilumab.2型炎症：度普利尤单抗成功治疗特应性皮炎、哮喘和高嗜酸性粒细胞增多症。
J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):261-263. doi: 10.18176/jiaci.0614. Epub 2020 Jul 30.
9
Effectiveness and safety of dupilumab for atopic dermatitis in a liver transplant recipient: a case report.度普利尤单抗治疗肝移植受者特应性皮炎的有效性和安全性：一例病例报告
J Dtsch Dermatol Ges. 2020 Jul;18(7):740-742. doi: 10.1111/ddg.14074. Epub 2020 Mar 25.
10
Onset of Schamberg Disease and Resolution of Alopecia Areata During Treatment of Atopic Dermatitis With Dupilumab.使用度普利尤单抗治疗特应性皮炎期间，尚伯格病的发作与斑秃的缓解。
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):65-66. doi: 10.18176/jiaci.0541. Epub 2020 Jun 3.

引用本文的文献

1
Use of dupilumab for recalcitrant bullous pemphigoid: A case report.度普利尤单抗用于治疗顽固性大疱性类天疱疮：一例报告。
SAGE Open Med Case Rep. 2024 Aug 22;12:2050313X241274855. doi: 10.1177/2050313X241274855. eCollection 2024.
2
Treatment patterns and factors associated with discontinuation of monoclonal antibodies.单克隆抗体的治疗模式及与停药相关的因素。
SAGE Open Med. 2024 Aug 19;12:20503121241271817. doi: 10.1177/20503121241271817. eCollection 2024.
3
Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies.
针对抑郁症的免疫靶向治疗：单克隆抗体抗抑郁作用的现有证据。
J Clin Psychiatry. 2024 Jun 24;85(3):23nr15243. doi: 10.4088/JCP.23nr15243.
4
A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities.一项关于度普利尤单抗治疗特应性皮炎患者的真实世界研究，其中包括患有恶性肿瘤和其他内科合并症的患者。
JAAD Int. 2024 Jan 17;15:5-11. doi: 10.1016/j.jdin.2024.01.002. eCollection 2024 Jun.
5
Dupilumab-Associated Arthritis: A Dermatology-Rheumatology Perspective.度普利尤单抗相关关节炎：皮肤科-风湿病学视角。
Am J Clin Dermatol. 2023 Nov;24(6):859-864. doi: 10.1007/s40257-023-00804-5. Epub 2023 Jun 22.
6
High loading-dose of dupilumab resulted in rapid disease control in pediatric patients with atopic dermatitis.高剂量度普利尤单抗治疗可快速控制特应性皮炎患儿的疾病。
Front Immunol. 2023 Apr 20;14:1160710. doi: 10.3389/fimmu.2023.1160710. eCollection 2023.
7
Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin-Induced Adverse Ocular Events-Incidence, Etiology, and Management.度普利尤单抗相关、特利鲁单抗相关和贝林妥欧单抗相关不良眼部事件——发生率、病因和管理。
Cornea. 2023 Apr 1;42(4):507-519. doi: 10.1097/ICO.0000000000003162. Epub 2022 Dec 15.
8
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials.度普利尤单抗治疗中度至重度特应性皮炎成人患者，无论疾病起病年龄如何均有效：两项3期临床试验的事后分析
Dermatol Ther (Heidelb). 2022 Dec;12(12):2731-2746. doi: 10.1007/s13555-022-00822-x. Epub 2022 Oct 21.
9
Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study.度普利尤单抗在常规临床护理中治疗特应性皮炎：PROLEAD前瞻性观察性研究中患者的基线特征
Dermatol Ther (Heidelb). 2022 Sep;12(9):2145-2160. doi: 10.1007/s13555-022-00791-1. Epub 2022 Aug 19.
10
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.度普利尤单抗在特应性皮炎患者中的真实世界有效性：电子病历数据集分析
Dermatol Ther (Heidelb). 2022 Jun;12(6):1337-1350. doi: 10.1007/s13555-022-00731-z. Epub 2022 May 11.